Task Force Overview

From LipidomicsWiki

(Difference between revisions)
Jump to: navigation, search
Current revision (08:17, 21 July 2011) (view source)
 
(6 intermediate revisions not shown.)
Line 1: Line 1:
The LipidomicNet consortium consists of six vertical (TFI-VI) and three horizontal integrative (TFVII-TFIX) task forces.<br>Specific enabling technologies and their applications (TF I-IV).<br>Mouse models (TF V).<br>Human clinical trials and ethics issues (TF VI).<br>Translational research (TF VII).<br>LipidomicNet (TF VIII).<br>Dissemination and training (TF IX).<br>  
The LipidomicNet consortium consists of six vertical (TFI-VI) and three horizontal integrative (TFVII-TFIX) task forces.<br>Specific enabling technologies and their applications (TF I-IV).<br>Mouse models (TF V).<br>Human clinical trials and ethics issues (TF VI).<br>Translational research (TF VII).<br>LipidomicNet (TF VIII).<br>Dissemination and training (TF IX).<br>  
   
   
-
 
-
<br>
 
-
 
-
 
== Overview of LipidomicNet Task Forces  ==
== Overview of LipidomicNet Task Forces  ==
The following table shows an overview of the task forces their Leaders and corresponding LipidomicNet partners.  
The following table shows an overview of the task forces their Leaders and corresponding LipidomicNet partners.  
-
 
-
 
-
<br>
 
-
<br>
 
-
 
-
 
-
<br>
 
-
 
{| class="prettytable FCK__ShowTableBorders"
{| class="prettytable FCK__ShowTableBorders"
Line 55: Line 43:
| [[User:Stefan Müllner|Dr. Stefan Müllner]]
| [[User:Stefan Müllner|Dr. Stefan Müllner]]
   
   
-
| [[User:Jens Hansen|Dr. Jens Hansen]]
+
| Dr. Stefan Wallner
   
   
| [[P01 UHREG|P01]], [[P07 UNIGRAZ|P07]], [[P16 EMBL|P16]], [[P20 PROTAGEN|P20]]
| [[P01 UHREG|P01]], [[P07 UNIGRAZ|P07]], [[P16 EMBL|P16]], [[P20 PROTAGEN|P20]]
Line 83: Line 71:
| Clinical trials and human ethics
| Clinical trials and human ethics
   
   
-
| [[User:Daniela Gasperikova|Daniela Gasperikova]]
+
| [[User:Daniela Gasperikova|Dr. Daniela Gasperikova]]
   
   
-
| Karpe
+
| [[User:Frederik Karpe|Dr. Fredrik Karpe]]
   
   
| [[P01 UHREG|P01]], [[P08 UGOT|P08]], [[P09 JUMC|P09]], [[P11 BRC HAS|P11]], [[P12 IEE SAS|P12]], [[P13 BABRAHAM|P13]], [[P14 UH|P14]], [[P15A UBO|P15A]], [[P15B UBO|P15B]], [[P22 UOXF.H7|22]], [[P23 MRC|P23]], and [[P24 JKU|P24]]
| [[P01 UHREG|P01]], [[P08 UGOT|P08]], [[P09 JUMC|P09]], [[P11 BRC HAS|P11]], [[P12 IEE SAS|P12]], [[P13 BABRAHAM|P13]], [[P14 UH|P14]], [[P15A UBO|P15A]], [[P15B UBO|P15B]], [[P22 UOXF.H7|22]], [[P23 MRC|P23]], and [[P24 JKU|P24]]
Line 105: Line 93:
| [[User:Gerd Schmitz|Prof. Dr. Gerd Schmitz]]
| [[User:Gerd Schmitz|Prof. Dr. Gerd Schmitz]]
   
   
-
| [[User:Isabell Dugail|Dr. Isabell Dugail]]
+
| [[User:Isabelle Dugail|Dr. Isabelle Dugail]]
   
   
| [[P01 UHREG|P01]], [[P04 INSERM|P04]], [[P06 ETHZ|P06]], [[P12 IEE SAS|P12]], [[P13 BABRAHAM|P13]], [[P15A UBO|P15A]]
| [[P01 UHREG|P01]], [[P04 INSERM|P04]], [[P06 ETHZ|P06]], [[P12 IEE SAS|P12]], [[P13 BABRAHAM|P13]], [[P15A UBO|P15A]]
Line 113: Line 101:
| LipidomicNet-Bioinformatics
| LipidomicNet-Bioinformatics
   
   
-
| [[User:Lennart Martens|Dr. Lennart Martens]]
+
| [[User:Juan Antonio Vizcaíno|Dr. Juan_Antonio_Vizcaíno]]
   
   
| [[User:Gerd Schmitz|Prof. Dr. Gerd Schmitz]]
| [[User:Gerd Schmitz|Prof. Dr. Gerd Schmitz]]
Line 125: Line 113:
| [[User:Aldona Dembinska-Kiec|Prof. Dr. Aldona Dembinska-Kiec]]
| [[User:Aldona Dembinska-Kiec|Prof. Dr. Aldona Dembinska-Kiec]]
   
   
-
| [[User:Juergen Jonas|Juergen Jonas]]
+
| [[User:Megi Sharikadze|Dr. Megi Sharikadze]]
   
   
| All partners
| All partners
|}
|}
-
<div style="border: 1px solid red; padding: 3px; font-weight: bold; margin-right: 10px;">Together the specialized vertical and the integrative horizontal Task Forces (TFs) will generate maximal integration and efficient dissemination and training.</div>  
+
<div style="border: 1px solid red; padding: 3px; font-weight: bold; margin-right: 10px;">Together the specialized vertical and the integrative horizontal Task Forces (TFs) will generate maximal integration and efficient dissemination and training.</div>
   
   
-
[[Site Map|Return to Site Map]]
 
-
 
-
 
[[Category:Task_Forces]]
[[Category:Task_Forces]]

Current revision

The LipidomicNet consortium consists of six vertical (TFI-VI) and three horizontal integrative (TFVII-TFIX) task forces.
Specific enabling technologies and their applications (TF I-IV).
Mouse models (TF V).
Human clinical trials and ethics issues (TF VI).
Translational research (TF VII).
LipidomicNet (TF VIII).
Dissemination and training (TF IX).

Overview of LipidomicNet Task Forces

The following table shows an overview of the task forces their Leaders and corresponding LipidomicNet partners.

Vertical Task Forces Taskforce chair co-chair Partner(s)
Task Force I Mass-spectrometric and chromatographic methods andpreanalytics for molecular lipid species analyses and stable isotope labelling Prof. Micheal Wakelam PhD. Gerhard Liebisch P01, P02, P04, P06, P07, P11, P13, P14, P15A, P15B, P17, P18, P19, P21, P22, P25
Task Force II Fluorescence-based lipidomic methods on intact cells, labelling lipidomic antibodies and proteins Dr. Christoph Thiele Prof. Dr. Aldona Dembinska-Kiec P01, P04, P09, P11, P13, P14, P15B, P23, P24
Task Force III Affinity binder, ELISA and proteomic mass-spectrometric techniques and reagents Dr. Stefan Müllner Dr. Stefan Wallner P01, P07, P16, P20
Task Force IV Gene-, Taqman- and Bead-array reagents and preanalytics (RNA/DNA, Agilent, Affymetrix, Illumina, ABI TLDAs etc) Prof. Dr. Gerd Schmitz Dr. Christian Wolfrum P01, P06, P09
Task Force V Mouse models Dr. Christian Wolfrum Van Dijk P02, P03, P04, P05, P06, and P07
Task Force VI Clinical trials and human ethics Dr. Daniela Gasperikova Dr. Fredrik Karpe P01, P08, P09, P11, P12, P13, P14, P15A, P15B, 22, P23, and P24
Horizontal Task Forces



Task Force VII Human/Mouse translational research Prof. Dr. Gerd Schmitz Dr. Isabelle Dugail P01, P04, P06, P12, P13, P15A
Task Force VIII LipidomicNet-Bioinformatics Dr. Juan_Antonio_Vizcaíno Prof. Dr. Gerd Schmitz P01, P06, P10, P16, P17, P18, P21, P22, P25
Task Force IX Dissemination, training and communication Prof. Dr. Aldona Dembinska-Kiec Dr. Megi Sharikadze All partners
Together the specialized vertical and the integrative horizontal Task Forces (TFs) will generate maximal integration and efficient dissemination and training.
Personal tools
Create a book